![](/img/cover-not-exists.png)
Sorafenib reduces the percentage of tumour infiltrating regulatory T cells in renal cell carcinoma patients
Ingrid M.E. Desar, J. (Hans) F.M. Jacobs, Christina A. Hulsbergen-vandeKaa, Wim J.G. Oyen, Peter F.A. Mulders, Winette T.A. van der Graaf, Gosse J. Adema, Carla M.L. van Herpen, I. (Jolanda) J.M. de VVolume:
129
Year:
2011
Language:
english
Pages:
6
DOI:
10.1002/ijc.25674
File:
PDF, 335 KB
english, 2011